Table 1.
Demographic and clinical data of ZIKV patients included in the study
| Patients (N = 9) M (±SD) | Controls (N = 9) M (±SD) | |
|---|---|---|
| Gender (Female) | 3 | 3 |
| Age (range 30–45 years old) | 35 (±4.46) | 32 (±5.91) |
| Period between ZIKV onset and MRI scan (months) | 5.6 (±1.5) | |
| Period between ZIKV onset and neurological manifestations (days) | 8.8 (±4.91) | |
| Guillain–Barre variant (# of patients with descending pattern) | 6 | |
| Hughes scale at admission | 3.2 (±0.97) | |
| Hughes scale at discharge | 2.3 (±0.87) | |
| Atypical and CNS manifestations | Acute | Subacute (scan) |
| Loss of visual acuity | 1 | 1 |
| Diplopia | 4 | 4 |
| Intense headache | 2 | 0 |
| Photophobia | 1 | 0 |
| Eye pain | 1 | 0 |
| Facial Diplegia | 6 | 5 |
| Vertigo | 1 | 1 |
| Prosopagnosia | 1 | 1 |
| Hyperacusis | 1 | 1 |
| Dysmorphopsia | 1 | 1 |